ACTEMRA tocilizumab (rch) 200 mg/10 mL injection concentrated vial

Roche Products Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f5fb57505bb08623
Product Name: ACTEMRA tocilizumab (rch) 200 mg/10 mL injection concentrated vial
Artg Id: 149404
Artg Name: ACTEMRA tocilizumab (rch) 200 mg/10 mL injection concentrated vial
Sponsor: Roche Products Pty Ltd
Company Detail Path: /organization/roche-products-pty-ltd
Artg Date: 2009-05-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: REPI
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-CMI-01335-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2011-PI-01333-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f5fb57505bb08623

Type

Standard